EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis.
about
Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis.Spinal Cord as an Adjunct to Brain Magnetic Resonance Imaging in Defining "No Evidence of Disease Activity" in Multiple Sclerosis.Optimizing outcomes in multiple sclerosis: consensus guidelines for the diagnosis and treatment of multiple sclerosis in Latin America.The Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis.A proposed roadmap for inpatient neurology quality indicatorsThe Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis.High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim reportContribution of magnetic resonance imaging to the diagnosis and monitoring of multiple sclerosis.Evaluating response to disease-modifying therapy in relapsing multiple sclerosis.Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliabilityCharacterizing Clinical and MRI Dissociation in Patients with Multiple Sclerosis.Chronic cerebrospinal venous insufficiency in multiple sclerosis: a historical perspective.Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox?Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.Changes in the metabolome and microRNA levels in biological fluids might represent biomarkers of neurotoxicity: A trimethyltin study.Dual-Sensitivity Multiple Sclerosis Lesion and CSF Segmentation for Multichannel 3T Brain MRI.Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis.Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis.Simultaneous Whole-Brain Segmentation and White Matter Lesion Detection Using Contrast-Adaptive Probabilistic Models
P2860
Q33694036-9A25533D-7B26-4C8B-9C5C-6D7225FE64E8Q33769234-F24797CF-8CBC-45F6-89EB-DAB09DFEEDA1Q35588410-EDA4ADD7-8D74-4199-B6C9-C7F0EE84618EQ37048758-327A34A1-A7F1-4B77-8B03-6B302C31D0ABQ37052740-D74DC5B1-AB6C-4882-AFA5-14EDEDE59E82Q37459099-521326DB-8F54-4170-880B-F8FA33A5F712Q37603718-0F1A194F-32C9-4430-B5A7-9B732501946AQ37995056-AE62BCFC-6714-4C50-8539-2C44CB5E8B43Q38375605-10F327BB-CA4B-403F-B958-CED452AD6298Q41613266-9D675D17-9CEF-439A-9D4C-87DEE009F6F2Q42359416-5475A533-8D8E-48AF-B7EA-3B8694D98289Q42925466-3F561416-9887-45F3-8997-D62C2F151783Q46912034-2C86CC87-84E2-4972-86CE-E253413738A0Q47242221-851EA362-1CFE-4A31-AC30-9B00F8E77A1FQ47654043-F5AF5428-DF79-49C0-A590-A2880DDBA1ABQ47918457-CAEC9215-68FC-4E38-AA8D-57C9FE5A214FQ48343851-097B1246-84F9-4262-80F7-5A47D62914E2Q48956772-5D68ABBA-092C-4180-B761-A0969A575417Q51167980-A4DE1F6F-1396-4128-97CF-F50CA27005C9Q55949080-128A8AC3-4DAB-4D4A-B09B-78335E6C69E6
P2860
EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis.
@en
EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis.
@nl
type
label
EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis.
@en
EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis.
@nl
prefLabel
EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis.
@en
EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis.
@nl
P2093
P2860
P1476
EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis.
@en
P2093
D L Arnold
J S Wolinsky
P2860
P304
P356
10.1111/J.1468-1331.2006.01543.X
P577
2006-04-01T00:00:00Z